Indoloquinoxaline compounds that selectively antagonize P-glycoprotein

Oncology Research

Volumn 12, Issue 5, 2000, Pages 219-229

  Smith, Charles D ^a   Myers, Cynthia B ^a   Zilfou, Jack T ^a   Smith, Staci N ^a   Lawrence, David S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Drug resistance; MRP1; P glycoprotein

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; AZIDE; AZIDOPINE; CISPLATIN; DIAGNOSTIC AGENT; DIHYDROPYRIDINE DERIVATIVE; DOXORUBICIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; QUINOXALINE DERIVATIVE; TUMOR PROTEIN; VINBLASTINE;

ARTICLE; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; PHOTOAFFINITY LABELING; SYNTHESIS; TOXICITY TESTING;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AZIDES; CELL SURVIVAL; CISPLATIN; DIHYDROPYRIDINES; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; PHOTOAFFINITY LABELS; QUINOXALINES; TOXICITY TESTS; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0034573361     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504001108747710     Document Type: Article

References (50)

1. Endicott, J. A.; Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58:137-171; 1989.
2. Gottesman, M. M.; Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62: 385-427; 1993.
3. Cole, S. P.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M.; Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654; 1992.
4. Grant, C. E.; Valdimarsson, G.; Hipfner, D. R.; Almquist, K. C.; Cole, S. P.; Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54:357-361; 1994.
5. Kruh, G. D.; Chan, A.; Myers, K.; Gaughan, K.; Miki, T.; Aaronson, S. A. Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Res. 54.: 1649-1652; 1994.
6. Cui, Y.; Konig, J.; Buchholz, J. K.; Spring, H.; Leier, I.; Keppler, D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol. 55: 929-937; 1999.
7. Zeng, H.; Bain, L. J.; Belinsky, M. G.; Kruh, G. D. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. Cancer Res. 59:5964-5967; 1999.
8. Kool, M.; van der Linden, M.; de Haas, M.; Scheffer, G. L.; de Vree, J. M.; Smith, A. J.; Jansen, G; Peters, G. J.; Ponne, N.; Scheper, R. J.; Elferink, R. P.; Baas, F.; Borst, P. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. USA 96:6914-6919; 1999.
9. Klein, I.; Sarkadi, B.; Varadi, A. An inventory of the human ABC proteins. Biochim. Biophys. Acta 1461:237-262; 1999.
10. Borst, P.; Evers, R.; Kool, M.; Wijnholds, J. A family of drug transporters: The multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92:1295-1302; 2000.
11. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41:1967-1972; 1981.
12. Ford, J. M.; Hait, J. N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42:155-199; 1990.
13. Raderer, M.; Scheithauer, W. Clinical trials of agents that reverse multidrug resistance. A literature review. Cancer 72:3553-3563; 1993.
14. Sikic, B. I. Modulation of multidrug resistance: A paradigm for translational clinical research. Oncology 13:183-187; 1999.
15. Smith, C. D. New compounds from cyanobacteria which circumvent multiple drug resistance. Drug News Perspect. 8:423-425; 1995.
16. Breuninger, L. M.; Paul, S.; Gaughan, K.; Miki, T.; Chan, A.; Aaronson, S. A.; Kruh, G. D. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res. 55:5342-5347; 1995.
17. Cole, S. P.; Sparks, K. E.; Fraser, K.; Loe, D. W.; Grant, C. E.; Wilson, G. M.; Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54:5902-5910; 1994.
18. Versantvoort, C. H.; Schuurhuis, G. J.; Pinedo, H. M.; Eekman, C. A.; Kuiper, C. M.; Lankelma, J.; Broxterman, H. J. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br. J Cancer 68:939-946; 1993.
19. Takeda, Y.; Nishio, K.; Niitani, H.; Saijo, N. Reversal of multi-drug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multidrug-resistant cell line. Int. J. Cancer 57:229-239; 1994.
20. Barrand, M. A.; Rhodes, T.; Center, M. S.; Twentyman, P. R. Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. Eur. J. Cancer 3:408-415; 1993.
21. van der Graaf, W. T.; de Vries, E. G.; Timmer-Bosscha, H.; Meersma, G. J.; Mesander, G.; Vellenga, E.; Mulder, N. H. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines. Cancer Res. 54:5368-5373; 1994.
22. Roe, M.; Folkes, A.; Ashworth, P.; Brumwell, J.; Chima, L.; Hunjan, S.; Pretswell, I.; Dangerfield, W.; Ryder, H.; Charlton, P. Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives. Bioorg. Med. Chem. Lett. 9:595-600; 1999.
23. Dantzig, A. H.; Shepard, R. L.; Law, K., L.; Tabas, L.; Pratt, S.; Gillespie, J. S.; Binkley, S. N.; Kuhfeld, M. T.; Starling, J. J.; Wrighton, S. A. Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities. J. Pharmacol. Exp. Ther. 290:854-862; 1999.
24. Wouters, W.; Janssens, F.; va Dun, J.; Krekels, M.; Smets, G. R101933 is an antagonist of Pgp and modulates resistance to different chemotherapy agents. Proc. Am. Assoc. Cancer Res. 40: 663; 1999.
25. Fairchild, C. R.; Ivy, S. P.; Kao-Shan, C. S.; Whang-Peng, J.; Rosen, N.; Israel, M. A.; Melera, P. W.; Cowan, K. H.; Goldsmith, M. E. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res. 47:5141-5148; 1987.
26. Schneider, E.; Horton, J. K.; Yang, C. H.; Nakagawa, M.; Cowan, K. H. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res. 54:152-158; 1994.
27. Smith, C. D.; Zilfou, J. T.; Stratmann, K.; Patterson, G. M.; Moore, R. E. Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance. Mol. Pharmacol. 47: 241-247; 1995.
28. Smith, C. D.; Prinsep, M. R.; Caplan, F. R.; Moore, R. E.; Patterson, G. M. Reversal of multiple drug resistance by tolyporphin, a novel cyanobacterial natural product. Oncol. Res. 6:211-218; 1994.
29. Zilfou, J. T.; Smith, C. D. Differential interactions of cytochalasins with P-glycoprotein. Oncol. Res. 7:435-443; 1995.
30. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82:1107-1112; 1990.
31. Marsh, W.; Sicheri, D.; Center, M. S. Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug. Cancer Res. 46: 4053-4057; 1986.
32. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254; 1976.
33. Leveille-Webster, C. R.; Arias, I. M. The biology of the P-glycoproteins. J. Membr. Biol. 143:89-102; 1995.
34. Zaman, G. J.; Versantvoort, C. H.; Smit, J. J.; Eijdems, E. W.; de Haas, M.; Smith, A. J.; Broxterman, H. J.; Mulder, N. H.; de Vries, E. G.; Baas, F.; Borst, P. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res. 53:1747-1750; 1993.
35. Abbaszadegan, M. R.; Futscher, B. W.; Klimecki, W. T.; List, A.; Dalton, W.. S. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res. 54:4676-4679; 1994.
36. Schneider, E.; Cowan, K. H.; Bader, H.; Toomey, S.; Schwartz, G. N.; Karp, J. E.; Burke, P. J.; Kaufmann, S. H. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 85:186-193; 1995.
37. Hart, S. M.; Ganeshaguru, K.; Hoffbrand, A. V.; Prentice, H. G.; Mehta, A. B. Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia. Leukemia 8:2163-2168; 1994.
38. Burger, H.; Nooter, K.; Sonneveld, P.; Van Wingerden, K. E.; Zaman, G. J.; Stoter, G. High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia. Br. J. Haematol. 88348-356; 1994.
39. Goldstein, L. J.; Galski, H.; Fojo, A.; Willingham, M.; Lai, S. L.; Gazdar, A.; Pirker, R.; Green, A.; Crist, W.; Brodeur, G. M.; Lieber, M.; Cossman, J.; Gottesman, M. M.; Pastan, I. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81:116-124; 1989.
40. Fojo, A. T.; Ueda, K.; Slamon, D. J.; Poplack, D. G.; Gottesman, M. M.; Pastan, I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA 84:265-269; 1987.
41. Bell, D. R.; Gerlach, J. H.; Kartner, N.; Buick, R. N.; Ling, V. Detection of P-glycoprotein in ovarian cancer: A molecular marker associated with multidrug resistance. J. Clin. Oncol. 3: 311-315; 1985.
42. Ma, D. D.; Scurr, R. D.; Davey, R. A.; Mackertich, S. M.; Harman, D. H.; Dowden, G.; Isbister, J. P.; Bell, D. R. Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia. Lancet 1:135-137; 1987.
43. Nooter, K.; Westerman, A. M.; Flens, M. J.; Zaman, G. J.; Scheper, R. J.; van Wingerden, K. E.; Burger, H.; Oostrum, R.; Boersma, T.; Sonneveld, P.; Sonneveld, P.; Gratama, J. W.; Kok, T.; Eggermont, A. M. M.; Bosman, F. T.; Stoter, G. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin. Cancer Res. 1:1301-1310; 1995.
44. Thomas, G. A.; Barrand, M. A.; Stewart, S.; Rabbitts, P. H.; Williams, E. D.; Twentyman, P. R. Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation. Eur. J. Cancer 11:1705-1709; 1994.
45. Schadendorf, D.; Makki, A.; Stahr, C.; van Dyck, A.; Wanner, R.; Scheffer, G. L.; Flens, M. J.; Scheper, R.; Henz, B. M. Membrane transport proteins associated with drug resistance expressed in human melanoma. Am. J. Pathol. 147:1545-1552; 1995.
46. Leier, I.; Jedlitschky, G.; Buchholz, U.; Cole, S. P.; Deeley, R. G.; Keppler, D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269:27807-27810; 1994.
47. Orlowski, S.; Mir, L. M.; Belehradek, J.; Garrigos, M. Effects of steroids and verapamil on P-glycoprotein ATPase activity: Progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem. J. 317:515-522; 1996.
48. Ayesh, S.; Shao, Y.-M.; Stein, W. D. Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein. Biochim. Biophys. Acta 1316:8-18; 1996.
49. Pascaud, C.; Garrigos, M.; Orlowski, S. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. Biochem. J. 333:351-358; 1998.
50. Dey, S.; Ramachandra, M.; Pastan, I.; Gottesman, M. M. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc. Natl. Acad. Sci. USA 94:10594-10599; 1997.